{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:10:55Z","timestamp":1784740255931,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15620-3","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:25:45Z","timestamp":1770092745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-gene DNA methylation profiles of tumor suppressor genes for prognostic prediction in gastric cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Soo Kyung","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjin","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinbayar","family":"Batochir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Bi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Joong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Kwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"15620_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L et al. Global Cancer Observatory: Cancer Today (Version 1.1). International Agency for Research on Cancer, Lyon, France. 2024 2025 20 May. Available from: https:\/\/gco.iarc.who.int\/today"},{"issue":"1","key":"15620_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-024-00720-8","volume":"13","author":"N Qin","year":"2025","unstructured":"Qin N, Fan Y, Yang T, Yang Z, Fan D. The burden of gastric cancer and possible risk factors from 1990 to 2021, and projections until 2035: findings from the global burden of disease study 2021. Biomark Res. 2025;13(1):5.","journal-title":"Biomark Res"},{"issue":"3","key":"15620_CR3","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"15620_CR4","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"15620_CR5","doi-asserted-by":"crossref","unstructured":"Kundu TK. Epigenetics: development and disease. Dordrecht ; New York: Springer; 2013. xxvi, 604\u201310.","DOI":"10.1007\/978-94-007-4525-4"},{"issue":"22","key":"15620_CR6","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1200\/JCO.2004.07.151","volume":"22","author":"PM Das","year":"2004","unstructured":"Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22(22):4632\u201342.","journal-title":"J Clin Oncol"},{"issue":"1","key":"15620_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/156652407779940413","volume":"7","author":"DS Shames","year":"2007","unstructured":"Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med. 2007;7(1):85\u2013102.","journal-title":"Curr Mol Med"},{"issue":"1","key":"15620_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000511243","volume":"102","author":"G Usui","year":"2021","unstructured":"Usui G, Matsusaka K, Mano Y, Urabe M, Funata S, Fukayama M, et al. DNA methylation and genetic aberrations in gastric cancer. Digestion. 2021;102(1):25\u201332.","journal-title":"Digestion"},{"issue":"Suppl 1","key":"15620_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2036.2004.01984.x","volume":"20","author":"TY Kim","year":"2004","unstructured":"Kim TY, Jong HS, Jung Y, Kim TY, Kang GH, Bang YJ. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther. 2004;20(Suppl 1):131\u201342.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"15620_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2217\/epi.15.4","volume":"7","author":"T Tahara","year":"2015","unstructured":"Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7(3):475\u201386.","journal-title":"Epigenomics"},{"key":"15620_CR11","doi-asserted-by":"publisher","first-page":"742578","DOI":"10.3389\/fgene.2021.742578","volume":"12","author":"C Zhu","year":"2021","unstructured":"Zhu C, Zhang S, Liu D, Wang Q, Yang N, Zheng Z, et al. A novel gene prognostic signature based on differential DNA methylation in breast cancer. Front Genet. 2021;12:742578.","journal-title":"Front Genet"},{"key":"15620_CR12","doi-asserted-by":"publisher","first-page":"3497810","DOI":"10.1155\/2020\/3497810","volume":"2020","author":"S Gong","year":"2020","unstructured":"Gong S, Ye W, Liu T, Jian S, Liu W. The development of Three-DNA methylation signature as a novel prognostic biomarker in patients with colorectal cancer. Biomed Res Int. 2020;2020:3497810.","journal-title":"Biomed Res Int"},{"key":"15620_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-8-86","volume":"8","author":"M Castro","year":"2010","unstructured":"Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. 2010;8:86.","journal-title":"J Transl Med"},{"key":"15620_CR14","first-page":"1","volume":"282","author":"T Gonzalez","year":"2024","unstructured":"Gonzalez T, Nie Q, Chaudhary LN, Basel D, Reddi H. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. Cancer Genet-Ny. 2024;282:1\u20138.","journal-title":"Cancer Genet-Ny"},{"key":"15620_CR15","doi-asserted-by":"crossref","unstructured":"Dong W, Lau CH, Li J, Huang Z, Li J, Wu W et al. Pan-cancer methylation analysis of Circulating cell-free DNA. Cancer Genet. 2025;(vol)296\u20137:182\u201395.","DOI":"10.1016\/j.cancergen.2025.07.014"},{"key":"15620_CR16","doi-asserted-by":"crossref","unstructured":"Choi B, Na Y, Whang MY, Ho JY, Han MR, Park SW et al. MGMT methylation is associated with human papillomavirus infection in cervical dysplasia: A longitudinal study. J Clin Med. 2023;12(19):6188 .","DOI":"10.3390\/jcm12196188"},{"key":"15620_CR17","doi-asserted-by":"publisher","first-page":"1395473","DOI":"10.3389\/fonc.2024.1395473","volume":"14","author":"H Kim","year":"2024","unstructured":"Kim H, Chu J, Do IG, Lee YP, Kim HK, Yang Y, et al. Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA. Front Oncol. 2024;14:1395473.","journal-title":"Front Oncol"},{"issue":"12","key":"15620_CR18","doi-asserted-by":"publisher","first-page":"e1321","DOI":"10.1634\/theoncologist.2019-0058","volume":"24","author":"J Koh","year":"2019","unstructured":"Koh J, Lee KW, Nam SK, Seo AN, Kim JW, Kim JW, et al. Development and validation of an Easy-to-Implement, practical algorithm for the identification of molecular subtypes of gastric cancer: prognostic and therapeutic implications. Oncologist. 2019;24(12):e1321\u201330.","journal-title":"Oncologist"},{"key":"15620_CR19","doi-asserted-by":"crossref","unstructured":"Kim H, Chu J, Do IG, Lee YP, Kim HK, Yang Y et al. Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA. Front Oncol. 2024;14:1395473.","DOI":"10.3389\/fonc.2024.1395473"},{"issue":"4","key":"15620_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","volume":"15","author":"T Oh","year":"2013","unstructured":"Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, et al. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn. 2013;15(4):498\u2013507.","journal-title":"J Mol Diagn"},{"issue":"1","key":"15620_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4143\/crt.2023.340","volume":"56","author":"S Oh","year":"2024","unstructured":"Oh S, Nam SK, Lee KW, Lee HS, Park Y, Kwak Y, et al. Genomic and transcriptomic characterization of gastric cancer with bone metastasis. Cancer Res Treat. 2024;56(1):219\u201337.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"15620_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5230\/jgc.2023.23.e5","volume":"23","author":"Y Park","year":"2023","unstructured":"Park Y, Nam SK, Seo SH, Park KU, Oh HJ, Park YS, et al. Comprehensive study of microsatellite instability testing and its comparison with immunohistochemistry in gastric cancers. J Gastric Cancer. 2023;23(2):264\u201374.","journal-title":"J Gastric Cancer"},{"key":"15620_CR23","doi-asserted-by":"crossref","unstructured":"Chatterjee N, Pulipaka B, Subbalakshmi AR, Jolly MK, Nair R. Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Comput Syst Oncol. 2023;3(3):e1051.","DOI":"10.1002\/cso2.1051"},{"key":"15620_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/bs.ctdb.2021.10.005","volume":"146","author":"CA Ettensohn","year":"2022","unstructured":"Ettensohn CA, Guerrero-Santoro J, Khor JM. Lessons from a transcription factor: Alx1 provides insights into gene regulatory networks, cellular reprogramming, and cell type evolution. Curr Top Dev Biol. 2022;146:113\u201348.","journal-title":"Curr Top Dev Biol"},{"issue":"11","key":"15620_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3748\/wjg.v16.i11.1409","volume":"16","author":"XR Chen","year":"2010","unstructured":"Chen XR, Wang JW, Li X, Zhang H, Ye ZY. Role of BMP3 in progression of gastric carcinoma in Chinese people. World J Gastroenterol. 2010;16(11):1409\u201313.","journal-title":"World J Gastroenterol"},{"issue":"5157","key":"15620_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.8153634","volume":"264","author":"A Kamb","year":"1994","unstructured":"Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264(5157):436\u201340.","journal-title":"Science"},{"issue":"7","key":"15620_CR27","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1053\/j.gastro.2009.02.085","volume":"136","author":"Y Watanabe","year":"2009","unstructured":"Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology. 2009;136(7):2149\u201358.","journal-title":"Gastroenterology"},{"issue":"53","key":"15620_CR28","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1038\/sj.onc.1210550","volume":"26","author":"Y Sugino","year":"2007","unstructured":"Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, Sugimoto T, et al. Epigenetic Silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene. 2007;26(53):7401\u201313.","journal-title":"Oncogene"},{"issue":"2","key":"15620_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MED.0000000000000617","volume":"28","author":"TW Moody","year":"2021","unstructured":"Moody TW, Jensen RT. Pituitary adenylate cyclase-activating polypeptide\/vasoactive intestinal peptide [Part 1]: biology, pharmacology, and new insights into their cellular basis of action\/signaling which are providing new therapeutic targets. Curr Opin Endocrinol Diabetes Obes. 2021;28(2):198\u2013205.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9","key":"15620_CR30","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/ijc.27318","volume":"130","author":"J Zhang","year":"2012","unstructured":"Zhang J, Li H, Yu JP, Wang SE, Ren XB. Role of SOCS1 in tumor progression and therapeutic application. Int J Cancer. 2012;130(9):1971\u201380.","journal-title":"Int J Cancer"},{"issue":"6","key":"15620_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4251\/wjgo.v12.i6.619","volume":"12","author":"J Sun","year":"2020","unstructured":"Sun J, Zheng MY, Li YW, Zhang SW. Structure and function of Septin 9 and its role in human malignant tumors. World J Gastrointest Oncol. 2020;12(6):619\u201331.","journal-title":"World J Gastrointest Oncol"},{"key":"15620_CR32","doi-asserted-by":"crossref","unstructured":"Vijayaragavan P, Purushothaman S, Arokiyaraj S, Rathi MA, Gopalakrishnan VK, Gatasheh MK et al. Aberrant DNA methylation of CDKN2B gene in the type 1 diabetes mellitus and analysis of epigenetic markers. J King Saud Univ - Sci. 2023;35(8)102896.","DOI":"10.1016\/j.jksus.2023.102896"},{"key":"15620_CR33","doi-asserted-by":"crossref","unstructured":"Mcbrearty N, Bahal D, Platero S. Fast-tracking drug development with biomarkers and companion diagnostics. J Cancer Metas Treat. 2024;10:3.","DOI":"10.20517\/2394-4722.2023.134"},{"issue":"3","key":"15620_CR34","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1093\/nar\/gnh032","volume":"32","author":"AS Yang","year":"2004","unstructured":"Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32(3):e38.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15620_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41587-019-0041-2","volume":"37","author":"Y Liu","year":"2019","unstructured":"Liu Y, Siejka-Zielinska P, Velikova G, Bi Y, Yuan F, Tomkova M, et al. Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol. 2019;37(4):424\u20139.","journal-title":"Nat Biotechnol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15620-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:16:55Z","timestamp":1772795815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15620-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15620"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15620-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with protocols approved by the IRB of SNUH (IRB number: H-2106-215-1231) and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}